CapitaLand Ascendas REIT (SGX:A17U)

CTI BioPharma Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Property, Plant & Equipment	17,866	17,657	17,595	17,225	17,144	14,577
Cash & Equivalents	180.95	167.59	221.08	216.54	368.03	276.54
Accounts Receivable	161.06	33.46	40.9	25.69	38.86	19.02
Other Receivables	-	58.5	35.06	37.19	23.97	20.96
Other Current Assets	67.54	90.67	80.16	83.14	24.76	36.41
Deferred Long-Term Tax Assets	5.2	18.29	13.97	5.05	-	1.48
Other Long-Term Assets	156.8	243.47	287.1	283.49	130.45	191.38
Total Assets	18,438	18,269	18,274	17,876	17,730	15,123
Current Portion of Long-Term Debt	939.08	835.5	807.13	668.86	624.11	194.21
Current Portion of Leases	42.22	39.32	39.92	39.7	36.66	37.22
Long-Term Debt	5,010	5,544	5,467	5,309	4,834	4,261
Long-Term Leases	622.7	590.55	606.4	607.61	567.99	572.73
Accounts Payable	416.34	47.34	35.31	36.72	26.91	26.09
Accrued Expenses	-	255.27	273.35	209.61	246.1	205.49
Current Income Taxes Payable	9.88	10.73	7.14	9.79	19.83	11.97
Current Unearned Revenue	-	30.32	41.98	48.98	54.11	19.44
Other Current Liabilities	98.69	157.08	181.34	124.03	136.91	122.22
Long-Term Deferred Tax Liabilities	113.83	119.66	152.74	172.39	117.77	55.94
Other Long-Term Liabilities	244.7	185.35	204.46	218.47	162.62	199.51
Total Liabilities	8,044	7,960	8,064	7,609	7,453	5,933
Common Stock	10,094	10,009	9,911	9,968	9,978	8,892
Comprehensive Income & Other	298.94	298.94	298.94	298.94	298.94	298.94
Total Common Equity	10,393	10,308	10,210	10,267	10,277	9,191
Minority Interest	1.74	0.67	-	-	-	-
Shareholders' Equity	10,394	10,309	10,210	10,267	10,277	9,191
Total Liabilities & Equity	18,438	18,269	18,274	17,876	17,730	15,123
Total Debt	7,160	7,155	7,167	6,789	6,689	5,292
Net Cash (Debt)	-6,979	-6,987	-6,946	-6,573	-6,321	-5,015
Net Cash Per Share	-1.58	-1.59	-1.61	-1.57	-1.53	-1.37
Filing Date Shares Outstanding	4,429	4,401	4,394	4,204	4,198	4,021
Total Common Shares Outstanding	4,429	4,400	4,394	4,204	4,198	4,021
Book Value Per Share	2.35	2.27	2.26	2.37	2.38	2.21
Tangible Book Value	10,393	10,308	10,210	10,267	10,277	9,191
Tangible Book Value Per Share	2.35	2.27	2.26	2.37	2.38	2.21

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.